SALVATORE, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1109
EU - Europa 557
AS - Asia 254
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 1935
Nazione #
US - Stati Uniti d'America 1069
IT - Italia 234
CN - Cina 206
IE - Irlanda 75
FI - Finlandia 71
SE - Svezia 40
UA - Ucraina 39
DE - Germania 38
CA - Canada 36
VN - Vietnam 30
GB - Regno Unito 21
IN - India 10
RO - Romania 10
FR - Francia 9
ZA - Sudafrica 9
IR - Iran 6
ES - Italia 5
BE - Belgio 4
BZ - Belize 4
EU - Europa 4
NL - Olanda 4
BG - Bulgaria 3
BR - Brasile 2
CH - Svizzera 2
DK - Danimarca 1
GR - Grecia 1
PH - Filippine 1
TR - Turchia 1
Totale 1935
Città #
Chandler 328
Millbury 96
Princeton 81
Napoli 66
Nanjing 65
Jacksonville 61
Boston 49
Des Moines 40
Beijing 39
Ottawa 33
Wilmington 33
Dong Ket 30
Lawrence 24
Nanchang 21
San Jose 18
Shenyang 17
Woodbridge 17
Norwalk 16
Houston 15
Hebei 13
Jiaxing 13
Tianjin 11
Falls Church 10
Redwood City 10
Muizenberg 9
San Mateo 9
Ann Arbor 8
Solopaca 8
Ashburn 7
Changsha 7
Naples 7
Augusta 6
Boardman 6
Fairfield 6
Kunming 6
Mugnano Di Napoli 6
Indiana 5
Timisoara 5
Belize City 4
Birmingham 4
Campagna 4
Dublin 4
Mezzolombardo 4
Orange 4
Sant'antimo 4
Ardabil 3
Barcelona 3
Buffalo 3
Grand Rapids 3
Hangzhou 3
Lanzhou 3
Milan 3
Minneapolis 3
New Delhi 3
Northampton 3
Rome 3
Sofia 3
Toronto 3
Atlanta 2
Bangalore 2
Bordeaux 2
Caserta 2
Chengdu 2
Courcelles 2
Dearborn 2
Ficarazzi 2
Fremont 2
Hammond 2
Las Vegas 2
New York 2
Paris 2
Pomeroy 2
Portici 2
Saint Louis 2
Seattle 2
Shanghai 2
Sunnyvale 2
Telese 2
Vanves 2
Waanrode 2
Acerra 1
Albuquerque 1
Ariano Irpino 1
Bacoli 1
Bari 1
Basel 1
Beaverton 1
Bergamo 1
Brandizzo 1
Brusciano 1
Catania 1
Catanzaro 1
Cerro Maggiore 1
Changchun 1
Chicago 1
Columbus 1
Dallas 1
Essen 1
Florence 1
Focsani 1
Totale 1332
Nome #
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 61
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 49
Assessing usability of a robotic-based AAL system: A pilot study with dementia patients 44
Brain structural damage in Friedreich's ataxia. 43
Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography 42
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 40
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 40
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 38
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 36
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity 35
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 34
Cognitive decline in Huntington's disease expansion gene carriers 33
Responsiveness of different rating instruments in spinocerebellar ataxia patients 32
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 31
Altered functional connectivity of interoception in illness anxiety disorder 31
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 30
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 30
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 29
A randomized clinical trial of lithium in multiple system atrophy. 29
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 29
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 28
Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample 28
[18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging 28
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 27
A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patients 27
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 27
Supratentorial and infratentorial damage in spinocerebellar ataxia 2: A diffusion-weighted MRI study. 26
Suicidal ideation in a European Huntington's disease population. 26
The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): Validation of Structural MR Imaging. 25
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 24
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 24
Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. 24
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task. 24
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 23
Internal jugular vein blood flow in multiple sclerosis patients and matched controls. 23
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 22
Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: A PET/MR hybrid scanner study. 22
The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness 22
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. 21
Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. 21
Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 21
Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. 21
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 21
Constructional Apraxia is related to Different Cognitive Defect's across Dementia 21
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's Disease 21
Possible gluten sensitivity in multiple system atrophy 20
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 20
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 20
Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics 19
Optical coherence tomography angiography findings in Huntington’s disease 19
SPINOCEREBELLAR ATAXIA 2: A BRAIN DIFFUSION-WEIGHTED MRI STUDY 18
Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia 18
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 18
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 18
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 18
The “crab sign”: an imaging feature of spinocerebellar ataxia type 48 18
Benign hereditary chorea due to a novel mutation of the thyroid transcription factor-1 gene. 17
Depression comorbidity in spinocerebellar ataxia. 17
The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families 17
Surface-enhanced Raman spectroscopy of tears: toward a diagnostic tool for neurodegenerative disease identification 17
Nigrostriatal involvement in ataxia with oculomotor apraxia type 1 16
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. 16
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 16
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon 16
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 16
High Prevalence of Spinal Magnetic Resonance Imaging Findings in Asymptomatic Young Adults (18-22 Yrs) Candidate to Air Force Flight 16
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. 15
Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study. 15
Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study. 15
Predictors of survival in a Huntington's disease population from southern Italy. 15
Structural connectivity in a single case of progressive prosopagnosia: The role of the right inferior longitudinal fasciculus. 15
A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease. 15
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. 15
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study 15
In vivo imaging of neurotransmission and brain receptors in dementia 14
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. 14
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 14
Spinocerebellar ataxia type 48: last but not least 14
Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families 13
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 12
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 12
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. 12
Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism 12
PRIN2015 n.2015KBL78T "Profilazione e adattivita' per una robotica assistiva incentrata sull'utente" 12
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 12
Clinical manifestations of intermediate allele carriers in Huntington disease 12
Whole body cholesterol metabolism is impaired in Huntington's disease. 11
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 11
Histogram analysis of DTI-derived indices reveals pontocerebellar degeneration and its progression in SCA2. 11
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 11
Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients 10
Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes 10
Multiple Sclerosis: Cerebral Circulation Time 10
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. 10
Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: an Italian multicenter study. 9
Is Anterior Communicating Artery Syndrome Related to Fornix Lesions? 9
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 9
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 8
Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. 7
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study. 7
Totale 2109
Categoria #
all - tutte 4336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201859 0000 00 69 152261
2018/2019167 00435 852 274 11764
2019/2020292 119111022 166 61 2203841
2020/2021352 17262531 2734 2016 56175231
2021/2022595 11486 533 1125 7968110235
2022/2023479 112633953 12383 60 0000
Totale 2147